IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2022i1p501-d1017856.html
   My bibliography  Save this article

Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs

Author

Listed:
  • Laura Krekulová

    (Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic
    4th Department of Internal Medicine, First Faculty of Medicine, Charles University in Prague, Kateřinská 32, 128 00 Prague 2, Czech Republic)

  • Tomáš Damajka

    (Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic)

  • Zuzana Krumphanslová

    (Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic)

  • Vratislav Řehák

    (Remedis, s.r.o., Vladimírova 10, 140 00 Prague 4, Czech Republic)

Abstract

The global effort to eliminate HCV infection requires new approaches to accessing and testing the affected population in a setting with as low of a threshold as possible. The focus should be on socially marginalized people who inject drugs (PWIDs) and who are not willing or able to visit standard medical services. With this vision, we established an outreach service—a testing point in an ambulance in the park in front of the Main Railway Station of the capital city of Prague—to provide bloodborne disease testing and treatment. The service was available every week on Wednesday afternoon. Over the initial two years of our experience, 168 unique people were tested. Of them, 82 (49%) were diagnosed with chronic HCV infection and were eligible for treatment with antivirals. Of these, 24 (29%) initiated antiviral treatment over the study period, and 17 (71%) of these individuals achieved a documented sustained virological response. Offering medical services in PWIDs’ neighborhoods helps overcome barriers and increase the chances that they will become patients and begin HCV treatment. The described outcomes appear promising for reaching the vision of linkage to the care of such a hard-to-reach population and can serve as a feasible model of care for further expansion.

Suggested Citation

  • Laura Krekulová & Tomáš Damajka & Zuzana Krumphanslová & Vratislav Řehák, 2022. "Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs," IJERPH, MDPI, vol. 20(1), pages 1-15, December.
  • Handle: RePEc:gam:jijerp:v:20:y:2022:i:1:p:501-:d:1017856
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/1/501/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/20/1/501/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2022:i:1:p:501-:d:1017856. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.